Fox Business - The Power to Prosper
Search Site

Stephen Sorace Archive

Get updates from Stephen Sorace

http://www.foxbusiness.com/archive/author/stephen-sorace/feed/rss

  • Five Tips for Saving on Your Summer Energy Bill

    Published August 07, 2012

    Cutting your energy costs can be tough, especially while trying to stay cool during the summer. Here are five ways of reducing your energy bill that won’t reduce your comfort.  

  • Chapwood Unveils New Cost-of-Living Index

    Published June 25, 2012

    Chapwood Investments recently announced the release of the Chapwood Index, which showed that the government has been underreporting the real cost-of-living increases through the consumer price index.

  • J.C. Penney President Departs, Shares Plummet

    Published June 19, 2012

    J.C. Penney (NYSE:JCP) shares plummeted Tuesday in the wake of the sudden departure of the retailer’s president, Michael Francis, which was announced on Monday.

  • Career Education Schools at Risk of Losing Accreditation

    Published June 13, 2012

    Shares of Career Education tumbled after the company said it has been asked to prove why 10 of its colleges should not lose their accreditation.

  • Shutterfly SVP and CTO Resigns

    Published June 11, 2012

    Shutterfly (NASDAQ:SFLY) announced that senior vice president and chief technology officer Neil Day will be resigning from his position, effective July 10, in order to spend more time with his family.

  • ExxonMobil Moving Some Employees to New Houston Facility

    Published June 06, 2012

    ExxonMobil announced it will be moving employees from its facilities in Virginia and Ohio to its campus currently under construction in Houston.

  • Kia Recalls Certain Rio Models

    Published June 05, 2012

    Kia Motors is recalling Rio car models from the years 2006 to 2008 due to the potential cracking of the front passenger seat sensor mat.

  • ImmunoGen Sees Promise in Modified Dosing of Lymphoma Drug

    Published June 04, 2012

    Shares of ImmunoGen Inc. lost steam in afternoon trading on Monday but were up as much as 7.7% earlier in the session on news that the company saw improvements in the safety of an investigational treatment for non-Hodgkin's lymphoma.